Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Hematopoietic Cell Transplantation (HCT) Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm: Systematic Review and Meta-Analysis Assessing the Role of Allogeneic and Autologous HCT

Razan Mohty, Hemant S. Murthy, Tea Reljic, Katelyn Keller, Ambuj Kumar, Mohamed A. Kharfan-Dabaja

Blood (2024) 144 (Supplement 1): 7906.

https://doi.org/10.1182/blood-2024-204306

Published: 2024

Journal Articles

Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis

Madiha Iqbal, MBBS, Tea Reljic, MPH, Ernesto Ayala, MD, Hemant S. Murthy, MD, Ambuj Kumar, MD MPH, Mohamed A Kharfan-Dabaja, MDMBA

Blood (2019) 134 (Supplement_1): 2106.

https://doi.org/10.1182/blood-2019-124955

Published: 2019

Journal Articles

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Benjamin Djulbegovic, MD, Tea Reljic, MPH, Shira Elqayam, PhD, Adam Cuker, MD MS, Iztok Hozo, PhD, Qi Zhou, PhD, Shelly-Anne Li, PhDc), Paul Alexander, PhD, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Holger Schünemann, MD, Gordon Guyatt, MD

Blood (2018) 132 (Supplement 1): 4707.

https://doi.org/10.1182/blood-2018-99-110132

Published: 2018

Journal Articles

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Shelly-Anne Li, PhD, Paul Alexander, PhD, Tea Reljic, MPH, Adam Cuker, MD MS, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Gordon Guyatt, MD, Holger Schünemann, MD, Benjamin Djulbegovic, MD

Blood (2018) 132 (Supplement 1): 2237.

https://doi.org/10.1182/blood-2018-99-111367

Published: 2018

Journal Articles

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Mak Djulbegovic, Stephanie Jaffe, Tea Reljic, Jason Beckstead, Adam Cuker, MD MS, Rob Kunkle, Benjamin Djulbegovic, MD

Blood (2017) 130 (Supplement 1): 4661.

https://doi.org/10.1182/blood.V130.Suppl_1.4661.4661

Published: 2017

Journal Articles

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Maya Khalil, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Mehdi Hamadani, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Ambuj Kumar, MD MPH, Mohamed A Kharfan-Dabaja, MD

Blood (2016) 128 (22): 3551.

https://doi.org/10.1182/blood.V128.22.3551.3551

Published: 2016

Journal Articles

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

Martine Extermann, MD PhD, Marina Sehovic, MD MPH, Tea Reljic, MPH, Jongphil Kim, PhD, Jeffrey E. Lancet, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 3998.

https://doi.org/10.1182/blood.V128.22.3998.3998

Published: 2016

Journal Articles

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Jongphil Kim, Martine Extermann, MD PhD, Jeffrey E. Lancet, MD, Najla H Al Ali, Tea Reljic, MPH, Marina Sehovic, MD MPH, Varun C Dhulipala, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 4007.

https://doi.org/10.1182/blood.V128.22.4007.4007

Published: 2016

Journal Articles

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Varun C Dhulipala, MD, Martine Extermann, MD PhD, Najla Al Ali, Jongphil Kim, Marina Sehovic, MD MPH, Tea Reljic, Benjamin Djulbegovic, MD PhD, Jeffrey E Lancet, MD

Blood (2015) 126 (23): 2505.

https://doi.org/10.1182/blood.V126.23.2505.2505

Published: 2015

Journal Articles

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

Jessica El-Asmar, MD, Tea Reljic, MPH, Ernesto Ayala, MD, Taiga Nishihori, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH, Mohamed A. Kharfan-Dabaja, MD

Blood (2015) 126 (23): 4493.

https://doi.org/10.1182/blood.V126.23.4493.4493

Published: 2015

Journal Articles

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Tea Reljic, MPH, Jessica El-Asmar, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Mehdi Hamadani, MD, Ambuj Kumar, MD, MPH

Blood (2015) 126 (23): 2097.

https://doi.org/10.1182/blood.V126.23.2097.2097

Published: 2015

Journal Articles

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Tea Reljic, M.S., Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD, Mohamed A Kharfan-Dabaja, MD

Blood (2014) 124 (21): 1306.

https://doi.org/10.1182/blood.V124.21.1306.1306

Published: 2014

Journal Articles

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Tea Reljic, BS, Ambuj Kumar, MD, MPH, Helen Mahoney, MPH, Branko Miladinovic, PhD, Mohamed A Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 1945.

https://doi.org/10.1182/blood.V122.21.1945.1945

Published: 2013

Journal Articles

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Jasmin Lacevic, Tea Reljic, BS, Najla El Jurdi, MD, Mohamed A Kharfan-Dabaja, MD, Taiga Nishihori, MD, Rami S. Komrokji, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 5372.

https://doi.org/10.1182/blood.V122.21.5372.5372

Published: 2013

Journal Articles

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Mohamed A. Kharfan-Dabaja, MD, Mehdi Hamadani, M.D, Tea Reljic, William I. Bensinger, MD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4519.

https://doi.org/10.1182/blood.V120.21.4519.4519

Published: 2012

Journal Articles

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Mohamed A. Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Tea Reljic, Joseph Pidala, MD, MS, Janelle Perkins, PharmD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4168.

https://doi.org/10.1182/blood.V120.21.4168.4168

Published: 2012

Journal Articles

Impact of National Cancer Institute's Common Toxicity Criteria and Common Terminology Criteria for Adverse Events on Quality of Treatment Related Harms Reporting: An Analysis of National Cancer Institute's Co-Operative Group Phase III Randomized Controlled Trials

Rahul Mhaskar, MPH, PhD, Hesborn Wao, PhD, Tea Reljic, BS, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD

Blood (2011) 118 (21): 673.

https://doi.org/10.1182/blood.V118.21.673.673

Published: 2011

Journal Articles

Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials

Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH, Branko Miladinovic, PhD, Asmita Mhaskar, MPH, Tea Reljic, BS, Sanja Galeb, BS, Rahul Mhaskar, MPH, PhD, Hozo Iztok, PhD, Dongsheng Tu, Heather Stanton, Christopher M Booth, Ralph M. Meyer, MD

Blood (2011) 118 (21): 508.

https://doi.org/10.1182/blood.V118.21.508.508

Published: 2011

Journal Articles

Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure

Karen Lin, MD, Tea Reljic, Ambuj Kumar, MD, MPH, Jeffrey E. Lancet, MD, Alan F. List, Rami S. Komrokji, MD

Blood (2010) 116 (21): 2913.

https://doi.org/10.1182/blood.V116.21.2913.2913

Published: 2010

Journal Articles

Comparative Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes

Tea Reljic, Neera Bhansali, PhD, Rami S. Komrokji, MD, Karen Lin, MD, Alan F. List, MD, Benjamin Djulbegovic, MD, PhD, David A. Fenstermacher, PhD, Jeffrey E. Lancet, MD, Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH

Blood (2010) 116 (21): 3995.

https://doi.org/10.1182/blood.V116.21.3995.3995

Published: 2010

NARROW

Hematopoietic Cell Transplantation (HCT) Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm: Systematic Review and Meta-Analysis Assessing the Role of Allogeneic and Autologous HCT

Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-Analysis

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Reduced-Intensity or Myeloablative Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: A Side-By-Side Systematic Review/Meta-Analysis

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T-Cell Lymphomas As Front-Line Consolidation or in the Relapsed/Refractory Setting: A Meta-Analysis

Myeloablative or Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma? a Systematic Review and Meta-Analysis

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Conservative Management Vs. Allogeneic Hematopoietic Cell Transplantation For Polycythemia Vera: A Systematic Review and Decision-Analysis

Comparative Efficacy of Tandem Autologous Versus Autologous Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Impact of National Cancer Institute's Common Toxicity Criteria and Common Terminology Criteria for Adverse Events on Quality of Treatment Related Harms Reporting: An Analysis of National Cancer Institute's Co-Operative Group Phase III Randomized Controlled Trials

Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials

Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure

Comparative Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only